ML20023C835
| ML20023C835 | |
| Person / Time | |
|---|---|
| Issue date: | 12/10/1979 |
| From: | Paperiello C NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION III) |
| To: | Strickler J NRC OFFICE OF INSPECTOR & AUDITOR (OIA) |
| Shared Package | |
| ML20023A415 | List:
|
| References | |
| FOIA-82-515 NUDOCS 8305180080 | |
| Download: ML20023C835 (1) | |
Text
f, *1 e
fIge rec,94 o
77* I UNITE D $T ATES
,e-NUCLE AR REGUL ATORY COMMISSION i
5.*,'. ~,. ff i V)
I H E GIO N ill Cl, f
,8 799 nooSEVELT noAo
\\..b,s '
GL EN ELLYN 1LLINotS 60137 g
- - - -[K(i10io79 MEMORANDUM FOR: Jerry Strickler, Office of Inspector and Auditor FROM:
C. J. Paperiello, Chief, Material Radiological Protection Section No. 1
SUBJECT:
NUCLEAR PHARMACY, INC., }IILWAUKEE WI LICENSE NO.48-174'66-0111D This memorandum is in response to your request to document my recollec-tion of statements made at the managernent meeting held in the Region III of fice on thrch 23, 1979.
On March 23, 1979, an enforcement meeting was held in the Region III offi e with representatives of Nuclear Pharmacy.
These representatives were:
Mr. Steve Wilkerson, Coordinator of Pharmacy Operations; Mr. Jon Reavis, Ibnager of the 1111waukee Of fice; and Dr. 111chael Zimmer, Ihnager Elchurst Office and Regional Director.
NRC representatives included:
James C. Keppler, Director; Charles E. Norelius, Assistant to the Director; A. B.
Davis, Chief, Fuel Facility and !bterials Safety Branch; B. B. Dicey, Radiation Specialist ; Evelyn R. Ibtson, Radiation Specialist; and rayself.
The purpose of the meeting was to determine why Nuclear Pharmacy distri-buted Union Carbide Xe-133 and what they would do to prevent recurrence in the future.
There was a lot of evasion on the part of Nuclear Pharmacy repres :ntatives with respect to the reason for their purchasing Union Carbide Xc-133.
Toward the end, Mr. J. Keppler asked Mr. Wilkerson a question (these are not the precise words), "When you ordered the Union Carbide Xenon did you know you were in noncompliance with the condition in your license?"
Mr. Wilkerson replied (again these are not the precise words), "Yes, but we thought there was suf ficient conflict between NRC and FDA regulations that this would be OK."
I am willing to testify under oath concerning the above rnatter.
-C a,
C. J.
aperiel o, Chief 1hterials Radiological Protection Section No. 1 8305180080 830412 PDR FOIA EMSHWILB2-515 PDR s
lb.O' h